HYPERTENSION Endothelin-receptor antagonists for treating hypertension

被引：0

作者：

Weir, Matthew R. ^{[1
]}

机构：

[1] Univ Maryland, Sch Med, Dept Med, Div Nephrol, Baltimore, MD 21201 USA

来源：

NATURE REVIEWS NEPHROLOGY | 2010年 / 6卷 / 04期

关键词：

RESISTANT HYPERTENSION; ASSOCIATION;

D O I：

10.1038/nrneph.2010.14

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

Are selective endothelin-receptor antagonists really an important new advance for treating patients with treatment-resistant hypertension? The evidence from a recent study leaves us with some uncertainty.

引用

页码：192 / 194

页数：4

共 8 条

[1] Resistant hypertension: Diagnosis, evaluation, and treatment - A Scientific Statement from the American Heart Association Professional Education Committee of the Council for High Blood Pressure Research [J].

Calhoun, David A. ;

Jones, Daniel ;

Textor, Stephen ;

Goff, David C. ;

Murphy, Timothy P. ;

Toto, Robert D. ;

White, Anthony ;

Cushman, William C. ;

White, William ;

Sica, Domenic ;

Ferdinand, Keith ;

Giles, Thomas D. ;

Falkner, Bonita ;

Carey, Robert M. .

HYPERTENSION, 2008, 51 (06) :1403-1419

[2] Characterization of resistant hypertension - Association between resistant hypertension, aldosterone, and persistent intravascular volume expansion [J].

Gaddam, Krishna K. ;

Nishizaka, Mari K. ;

Pratt-Ubunama, Monique N. ;

Pimenta, Eduardo ;

Aban, Inmaculada ;

Oparil, Suzanne ;

Calhoun, David A. .

ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (11) :1159-1164

[3] Resistant Hypertension and Hyperaldosteronism [J].

Gonzaga, Carolina C. ;

Calhoun, David A. .

CURRENT HYPERTENSION REPORTS, 2008, 10 (06) :496-503

[4]

SAITO Y, 1990, NEW ENGL J MED, V322, P205

[5] Dose-Dependent Acute and Sustained Renal Effects of the Endothelin Receptor Antagonist Avosentan in Healthy Subjects [J].

Smolander, J. ;

Vogt, B. ;

Maillard, M. ;

Zweiacker, C. ;

Littke, T. ;

Hengelage, T. ;

Burnier, M. .

CLINICAL PHARMACOLOGY & THERAPEUTICS, 2009, 85 (06) :628-634

[6] A selective endothelin-receptor antagonist to reduce blood pressure in patients with treatment-resistant hypertension: a randomised, double-blind, placebo-controlled trial [J].

Weber, Michael A. ;

Black, Henry ;

Bakris, George ;

Krum, Henry ;

Linas, Stuart ;

Weiss, Robert ;

Linseman, Jennifer V. ;

Wiens, Brian L. ;

Warren, Marshelle S. ;

Lindholm, Lars H. .

LANCET, 2009, 374 (9699) :1423-1431

[7]

WEIR MR, CLIN J AM S IN PRESS

[8] Avosentan Reduces Albumin Excretion in Diabetics with Macroalbuminuria [J].

Wenzel, Rene R. ;

Littke, Thomas ;

Kuranoff, Susan ;

Juergens, Christiania ;

Bruck, Heike ;

Ritz, Eberhard ;

Philipp, Thomas ;

Mitchell, Anna .

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2009, 20 (03) :655-664

← 1 →